Skip to main content

Genetic Testing

Metatranscriptome Sequencing

Metatranscriptome sequencing is intended to profile RNA expressed in a community or mixed sample for research. The organisms, material, and workflow require confirmation.

About this service

Metatranscriptomics studies RNA transcripts in a mixed biological community or sample and can provide a time- and method-dependent view of gene expression. The original description does not clearly define the community, sample type, or workflow for this service; those details must be confirmed. RNA data can inform research into microbial activity but do not diagnose a patient's disease, monitor treatment effectiveness, or establish causality.

Service highlights

  • Named metatranscriptome sequencing service.
  • May support research into transcript activity in a defined mixed sample.
  • Community, specimen, and workflow are not established in the available material.

Who may consider it

  • Researchers studying microbial communities and expressed RNA.
  • Research groups with a defined metatranscriptomics project, subject to confirmation.

What to expect

Confirm which organisms and sample types are in scope, accepted material and intake instructions, preparation/sequencing/analysis inclusions, data outputs, turnaround, current availability, and a current quotation.

Scope and limitations

Metatranscriptomic sequencing is research analysis of RNA in a sample, not a clinical diagnostic or disease-monitoring test on the evidence available. Results depend on sampling and methods and cannot alone establish disease, causality, or treatment efficacy.

Frequently asked questions

What is metatranscriptome sequencing for?

It is named as sequencing for RNA-expression study in a mixed sample; confirm whether the intended focus is a microbial community and which organisms are covered.

What material and outputs are needed?

Confirm sample requirements, RNA preparation and sequencing steps, analysis scope, and whether raw or processed data are delivered.

Can it diagnose disease or monitor treatment?

No such clinical use is established here. Confirm research limitations, current availability, turnaround, and quotation.